Recent Material Events - Novadel Pharma, Inc (NVD)

Filing Date	Description
2008-10-21	As previously disclosed on a Current Report on Form 8-K filed on May 7, 2008 with the Securities and Exchange Commission, referred to herein as the SEC, NovaDel Pharma Inc., referred to herein as the Company, entered into a binding Securities Purchas ...
2008-09-19	On September 18, 2008, NovaDel Pharma Inc., a Delaware corporation, issued a press release to announce that the United States Food and Drug Administration had extended the Prescription Drug User Fee Act deadline for Zolpimist (zolpidem tartrate) Oral ...
2008-09-11	On September 8, 2008, NovaDel Pharma Inc., a Delaware corporation (the “Company”), held its 2008 Annual Meeting of Stockholders (the “Annual Meeting”). The total number of outstanding shares of common stock entitled to vote at the ...
2008-09-08	On September 8, 2008, beginning at 9:00 a.m., Eastern Standard Time, the Annual Meeting of Stockholders of NovaDel Pharma Inc., a Delaware corporation (the “Company”), will be held at the offices of Morgan, Lewis & Bockius LLP, located ...
2008-09-04	On September 4, 2008, NovaDel Pharma Inc. (the “Company”), a Delaware corporation, issued a press release to announce that data from its Pilot Efficacy Study of its Oral Spray formulation of sumatriptan (Sumatriptan OS) compared to sumatrip ...
2008-06-03	As previously disclosed on a Current Report on Form 8-K and filed with the Securities and Exchange Commission, referred to herein as the SEC, on May 7, 2008, on May 6, 2008, NovaDel Pharma Inc., referred to herein as the company, entered into a bindi ...
2008-05-28	On May 28, 2008, NovaDel Pharma Inc., referred to herein as the Company, and ProQuest Investments II, L.P., ProQuest Investments II Advisors Fund, L.P. and ProQuest Investments III, L.P. (the “ Purchasers ”), entered into Amendment No. 1 (t ...
2008-05-20	On May 19, 2008, NovaDel Pharma Inc. (“NovaDel”), a Delaware corporation, issued a press release to announce that it had entered into a collaboration agreement with BioAlliance Pharma SA (the “Agreement”) for the development and c ...
2008-05-16	On May 15, 2008, NovaDel Pharma Inc. (“NovaDel”), a Delaware corporation, issued a press release to report its financial results for the first quarter ended March 31, 2008. A copy of the press release is furnished pursuant to this Item 2.02 ...
2008-05-07	On May 6, 2008, NovaDel Pharma Inc., referred to herein as the Company, entered into a binding Securities Purchase Agreement to sell up to $4,000,000 of secured convertible promissory notes, referred to herein as the convertible notes, and accompanyi ...